AAV-ChAT-jGCaMP7s-WPRE-hGH pA

Research background

This AAV enables optical readout of activity by expressing a genetically encoded calcium indicator (GECI). Calcium imaging provides population-level or single-cell measurements of activity dynamics over time.

Mechanism and expected readouts

GECIs report intracellular calcium transients as fluorescence changes, which correlate with spiking and synaptic activity depending on cell type and indicator kinetics. Signal interpretation benefits from attention to kinetics, baseline fluorescence, and potential buffering at high expression levels.

Expression design and interpretation

Expression is driven by the ChAT promoter, which determines where and how strongly the payload is expressed in your system (cholinergic neurons). The construct's regulatory logic controls where/when the payload is active; expression is constitutive (no recombinase or inducer required). The encoded payload is intended to support the stated experimental function (e.g., modulation, sensing, labeling, or control).

Subcellular targeting elements (when present) can bias localization and should be confirmed by imaging in your preparation.

Common research applications

• In vivo calcium imaging (1-photon miniscope or 2-photon microscopy)
• Population dynamics during behavior or sensory stimulation
• Ex vivo slice imaging for circuit physiology

Experimental considerations

• Choose imaging frame rate and excitation power to balance SNR and photobleaching
• Plan analysis around indicator kinetics (rise/decay) and motion correction needs
• Use appropriate controls for neuropil contamination and baseline drift

Controls and validation

Typical validation includes confirming expression pattern and level, verifying functional activity with an assay matched to the payload (e.g., imaging, electrophysiology, pharmacology, or behavior), and using appropriate negative controls.

• Sales Terms and Conditions (PDF)
• SDS (PDF)

At present, the main purification approaches for rAAV include:

• Ultracentrifugation density-gradient methods, using cesium chloride (CsCl) or iodixanol as the gradient medium;
• Chemical reagent precipitation/extraction methods, mainly using PEG, ammonium sulfate, chloroform, etc.;
• Chromatographic purification methods, primarily based on affinity and ion-exchange principles.

Depending on customers’ different application needs, we can integrate multiple methods to produce high-titer, high-purity, high-quality rAAV viral products.

Can’t find the AAV you need—or require a custom design and packaging service? We offer end-to-end support for diverse research and therapeutic needs, including vector design and cloning, AAV packaging services (serotype/capsid selection and production), QC & characterization (project-appropriate testing and documentation), and library preparation for pooled or library-style workflows (project dependent). Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.